Friday, 30 November 2012

New mechanism for cancer progression discovered

The protein called Ras plays an important role in the control of cellular growth. Researchers have focused on this protein because mutations in its gene are found in over 30% of all cancers, making it the most prevalent human oncogene.

However, researchers from Harvard and the University of North Carolina Lineberger Comprehensive Cancer Center have discovered an alternative mechanism for activating Ras; this new way does not require mutation or hormonal stimulus. In healthy cells, Ras transmits hormone signals that prompt cell growth and the development of organs and tissues, but if a mutation occurs these signals can become chronically activated, leading to tumour initiation and progression.

In an article published by Nature Structural and Molecular Biology, the UNC and Harvard teams discovered that it is possible to lock Ras into an active signalling state. They did this by modifying Ras at a specific site with a single small protein called ubiquitin, a process known as monoubiquitination, in which the action of another protein, known as the GTPase activating protein, is disrupted.

Because of the strong link between Ras and cancer, it should be an attractive target for drug therapies, but despite considerable efforts to develop treatments that target the protein, it is now considered to be 'undruggable'. The researchers next step then will be to gain a better understanding of its role in cancer progression, firstly using cells then moving on to animals and eventually cancer patients.

Jack

No comments:

Post a Comment